Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature-Reference-Cited by-同舟云学术

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature

Published:2022-06-20 Issue:2 Volume:26 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Smith Tim¹,Lane Brian¹,More Elisabet¹,Valentine Helen¹,Lunj Sapna¹,Abdelkarem Omneya²,Irlam‑Jones J.¹,Shabbir Rekaya¹,Vora Shrushti¹,Denley Helen³,Reeves Kimberley¹,Hoskin Peter¹,Choudhury Ananya¹,West Catharine¹

Affiliation:

1. Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester M20 4GJ, UK

2. Chemical Pathology Department, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt

3. Pathology Centre, Shrewsbury and Telford NHS Trust, Royal Shrewsbury Hospital, Shrewsbury SY3 8XQ, UK

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. Patient-reported quality of life outcomes in patients treated for muscle-invasive bladder cancer with radiotherapy ± chemotherapy in the BC2001 phase III randomised controlled trial;Huddart;Eur Urol,2020

3. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: A pooled analysis of radiation therapy oncology group protocols 8802, 8903, 9506, 9706, 9906, and 0233;Mak;J Clin Oncol,2014

4. Radiotherapy resistance: Identifying universal biomarkers for various human cancers;Larionova;J Cancer Res Clin Oncol,2022

5. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma;Hoskin;J Clin Oncol,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts;Cancer Genomics - Proteomics;2024-06-29

2. Gene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response;Genes;2024-05-26

3. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy;Seminars in Cancer Biology;2023-12

4. Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD);International Journal of Radiation Oncology*Biology*Physics;2023-12